2026 Josep M. Llovet: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	143	1461	1351	15	14	481	147583

Research.com Recognitions

2025 - Research.com Medicine in Spain Leader Award

Overview

Josep M. Llovet is affiliated with the University of Barcelona in Spain and is primarily engaged in research within the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work is focused on subfields such as Hepatology, Oncology, Cancer Research, Epidemiology, and Molecular Biology.

The scientist's research topics include:

Hepatocellular Carcinoma Treatment and Prognosis
Cancer Immunotherapy and Biomarkers
Liver Disease Diagnosis and Treatment
Pancreatic and Hepatic Oncology Research
Ferroptosis and cancer prognosis
Cancer Genomics and Diagnostics
Cholangiocarcinoma and Gallbladder Cancer Studies

Major venues where Josep M. Llovet has published include:

Journal of Hepatology
Journal of Clinical Oncology
JHEP Reports
Clinical Cancer Research
Annals of Oncology

Among recent papers authored or co-authored by Josep M. Llovet are:

Hepatocellular carcinoma, 2021, Nature Reviews Disease Primers
Immunotherapies for hepatocellular carcinoma, 2021, Nature Reviews Clinical Oncology
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma, 2021, Nature Reviews Gastroenterology & Hepatology

Other prominent papers relevant to this scientist's field but with different primary authorship include:

AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma, 2023, Hepatology
Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma, 2020, Journal of Clinical Oncology

Frequent co-authors of Josep M. Llovet include:

Richard S. Finn
Roser Pinyol
Masatoshi Kudo
Augusto Villanueva
Daniela Sia

Best Publications

Sorafenib in Advanced Hepatocellular Carcinoma

Josep M. Llovet;Sergio Ricci;Vincenzo Mazzaferro;Philip Hilgard

15636
Citations
EASL-EORTC clinical practice guidelines : management of hepatocellular carcinoma

Peter R. Galle;Alejandro Forner;Josep M. Llovet;Vincenzo Mazzaferro

12833
Citations
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference

Jordi Bruix;Morris Sherman;Josep M Llovet;Michel Beaugrand

5061
Citations
PROGNOSIS OF HEPATOCELLULAR CARCINOMA : THE BCLC STAGING CLASSIFICATION

Josep M. Llovet;Concepció Brú;Jordi Bruix

4309
Citations
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.

Josep M Llovet;Maria Isabel Real;Xavier Montaña;Ramon Planas

3827
Citations
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

Josep M. Llovet;Jordi Bruix

3705
Citations
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial

Jordi Bruix;Shukui Qin;Philippe Merle;Alessandro Granito

3412
Citations
EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer

Josep M. Llovet;Michel Ducreux;Riccardo Lencioni;Adrian M. Di Bisceglie

2323
Citations
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

Vincenzo Mazzaferro;Josep M Llovet;Rosalba Miceli;Sherrie Bhoori

2147
Citations
Hepatocellular carcinoma.

Josep M Llovet;Robin Kate Kelley;Augusto Villanueva;Amit G Singal

2075
Citations
Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation

Josep M. Llovet;Josep Fuster;Jordi Bruix

2026
Citations
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma

Josep M. Llovet;Adrian M. Di Bisceglie;Jordi Bruix;Barnett S. Kramer

2012
Citations
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets

Kornelius Schulze;Sandrine Imbeaud;Eric Letouzé;Ludmil B. Alexandrov;Ludmil B. Alexandrov

1655
Citations
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

Scott M. Wilhelm;Lila Adnane;Philippa Newell;Augusto Villanueva

1647
Citations
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.

Andrew X Zhu;Yoon-Koo Kang;Chia-Jui Yen;Richard S Finn

1637
Citations
Molecular therapies and precision medicine for hepatocellular carcinoma

Josep M. Llovet;Josep M. Llovet;Robert Montal;Daniela Sia;Richard S. Finn

1563
Citations
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma

John Bridgewater;Peter R. Galle;Shahid A. Khan;Josep M. Llovet

1519
Citations
Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.

Xavier Forns;Sergi Ampurdanès;Josep M. Llovet;John Aponte

1490
Citations
Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials

Josep M. Llovet;Javier Bustamante;Antoni Castells;Ramon Vilana

1462
Citations
Prognostic prediction and treatment strategy in hepatocellular carcinoma

Jordi Bruix;Josep M. Llovet

1394
Citations

Frequent Co-Authors

Jordi Bruix University of Barcelona

Yujin Hoshida The University of Texas Southwestern Medical Center

Vincenzo Mazzaferro University of Milan

Myron Schwartz Icahn School of Medicine at Mount Sinai

Swan N. Thung Icahn School of Medicine at Mount Sinai

Masatoshi Kudo Kindai University

Scott L. Friedman Icahn School of Medicine at Mount Sinai

Richard S. Finn University of California, Los Angeles

Andrew X. Zhu Harvard University

Peter R. Galle Johannes Gutenberg University of Mainz

External Links

Personal website of Josep M. Llovet

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Exploring Medicine in the USA opens doors to varied healthcare careers, many of which can be accessed through online programs. For those aiming for advanced clinical practice, finding the cheapest dnp program can be a cost-effective path to becoming a nurse practitioner or clinical leader.

Pharmacists play a vital role in healthcare, and earning an online pharmd is an increasingly accessible route for those who wish to combine flexibility with rigorous training.

High school students considering a medical path can get a head start through the best online schools for high school students that offer health information management programs, giving early insight into healthcare systems.

Meanwhile, those interested in administrative roles should consider how affordable a program can be by asking how much is medical billing and coding school. These programs prepare students for in-demand jobs in medical billing and coding, often with flexible, online study options.